Page 55 - AN-2-3

Advanced Neurology TRPM7 signaling in glioblastoma

migration and proliferation of human glioblastoma cells by PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations.
activating transient receptor potential melastatin 7 channels. Nucleic Acids Res, 43: D512–D520.
J Cell Mol Med, 22: 6327–6337.
30. Czirják G, Enyedi P, 2006, Targeting of calcineurin to
https://doi.org/10.1111/jcmm.13931 an NFAT-like docking site is required for the calcium-
22. Turlova E, Wong R, Xu B, et al., 2021, TRPM7 mediates dependent activation of the background K+ channel,
neuronal cell death upstream of calcium/calmodulin- TRESK. J Biol Chem, 281: 14677–14682.
dependent protein kinase II and calcineurin mechanism in https://doi.org/10.1074/jbc.M602495200
neonatal hypoxic-ischemic brain injury. Transl Stroke Res,
12: 164–184. 31. Li H, Rao A, Hogan PG, 2011, Interaction of calcineurin
with substrates and targeting proteins. Trends Cell Biol,
https://doi.org/10.1007/s12975-020-00810-3 21: 91–103.
23. Brun M, Glubrecht DD, Baksh S, et al., 2013, Calcineurin https://doi.org/10.1016/j.tcb.2010.09.011
regulates nuclear factor I dephosphorylation and activity in
malignant glioma cell lines. J Biol Chem, 288: 24104–24115. 32. Czirják G, Enyedi P, 2014, The LQLP calcineurin docking
site is a major determinant of the calcium-dependent
https://doi.org/10.1074/jbc.M113.455832 activation of human TRESK background K+ channel. J Biol
24. Sliwa M, Markovic D, Gabrusiewicz K, et al., 2007, The Chem, 289: 29506–29518.
invasion promoting effect of microglia on glioblastoma cells https://doi.org/10.1074/jbc.M114.577684
is inhibited by cyclosporin A. Brain, 130: 476–489.
33. Ryazanova LV, Dorovkov MV, Ansari A, et al., 2004,
https://doi.org/10.1093/brain/awl263 Characterization of the protein kinase activity of TRPM7/
25. Kaleka KS, Petersen AN, Florence MA, et al., 2012, Pull- ChaK1, a protein kinase fused to the transient receptor
down of calmodulin-binding proteins. J Vis Exp, 59: 3502. potential ion channel. J Biol Chem, 279: 3708–3716. https://
doi.org/10.1074/jbc.M308820200
https://doi.org/10.3791/3502
34. Yang X, Li G, Xue Q, et al., 2017, Calcineurin/P-ERK/
26. Han W, Ming M, He TC, et al., 2010, Immunosuppressive Egr-1 pathway is involved in fear memory impairment after
cyclosporin A activates AKT in keratinocytes through isoflurane exposure in mice. Sci Rep, 7: 13947.
PTEN suppression: Implications in skin carcinogenesis.
J Biol Chem, 285: 11369–11377. https://doi.org/10.1038/s41598-017-13975-z
https://doi.org/10.1074/jbc.M109.028142 35. Schreck KC, Allen AN, Wang J, et al., 2020, Combination
MEK and mTOR inhibitor therapy is active in models of
27. Kim TY, Shin SK, Song MY, et al., 2012, Identification of glioblastoma. Neurooncol Adv, 2: vdaa138.
the phosphorylation sites on intact TRPM7 channels from
mammalian cells. Biochem Biophys Res Commun, 417: https://doi.org/10.1093/noajnl/vdaa138
1030–1034. 36. Kim JY, Kim YJ, Lee S, et al., 2009, The critical role of ERK
https://doi.org/10.1016/j.bbrc.2011.12.085 in death resistance and invasiveness of hypoxia-selected
glioblastoma cells. BMC Cancer, 9: 27.
28. Clark K, Middelbeek J, Morrice NA, et al., 2008, Massive
autophosphorylation of the Ser/Thr-rich domain controls https://doi.org/10.1186/1471-2407-9-27
protein kinase activity of TRPM6 and TRPM7. PLoS One, 3: 37. Behrooz AB, Talaie Z, Jusheghani F, et al., 2022, Wnt and
e1876.
PI3K/Akt/mTOR survival pathways as therapeutic targets in
https://doi.org/10.1371/journal.pone.0001876 glioblastoma. Int J Mol Sci, 23: 1353.
29. Hornbeck PV, Zhang B, Murray B, et al., 2015, https://doi.org/10.3390/ijms23031353

Volume 2 Issue 3 (2023) 10 https://doi.org/10.36922/an.334